Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study

References

• Burr J, Azuara-Blanco A, Avenell A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2005;2005:Cd004399.
   Google Scholar
• Hitchings R. Initial treatment for open-angle glaucoma- medical, laser, or surgical? Surgery is the treatment of choice for open-angle glaucoma. Arch Ophthalmol 1998;116:241–242.
   PubMedGoogle Scholar
• Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983;101:795–798.
   PubMedGoogle Scholar
• Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003;48:314–346.
   PubMed Web of Science ®Google Scholar
• Fluorouracil Filtering Surgery Study one-year follow-up. The Fluorouracil Filtering Surgery Study Group. Am J Ophthalmol 1989;108:625–635.
   PubMed Web of Science ®Google Scholar
• Khaw PT, Sherwood MB, MacKay SL, et al. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 1992;110:1150–1154.
   PubMed Web of Science ®Google Scholar
• Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol 1991;109:1693–1698.
   PubMed Web of Science ®Google Scholar
• Singh K, Mehta K, Shaikh NM, et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil: prospective randomized clinical trial. Ophthalmology 2000;107:2305–2309.
   PubMed Web of Science ®Google Scholar
• Skuta GL, Beeson CC, Higginbotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99:438–444.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990;97:1204–1210.
   PubMed Web of Science ®Google Scholar
• Greenfield DS, Stevens RK, Musch DC, et al. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943–949.
   PubMedGoogle Scholar
• Suñer IJ, Greenfield DS, Miller MP, et al. Hypotony maculopathy after filtering surgery with mitomycin C: incidence and treatment. Ophthalmology 1997;104:207–214; discussion 214-5.
   PubMed Web of Science ®Google Scholar
• Wolner B, Liebmann JM, Sassani JW, et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991;98:1053–1060.
   PubMed Web of Science ®Google Scholar
• Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol 1993;116:314–326.
   PubMed Web of Science ®Google Scholar
• Georgoulas S, Dahlmann-Noor A, Brocchini S, Khaw PT. Modulation of wound healing during and after glaucoma surgery. Prog Brain Res 2008;173:237–254.
   PubMed Web of Science ®Google Scholar
• Grewal DS, Jain R, Kumar H, Grewal SPS. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology 2008;115:2141–2145.e2.
   PubMed Web of Science ®Google Scholar
• How A, Chua JLL, Charlton A, et al. Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2010;51:928–932.
   PubMed Web of Science ®Google Scholar
• Li Z, Bergen TV, de Veire SV, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2009;50:5217–5225.
   PubMed Web of Science ®Google Scholar
• Memarzadeh F, Varma R, Lin L-T, et al. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 2009;50:3233–3237.
   PubMed Web of Science ®Google Scholar
• Takihara Y, Inatani M, Kawaji T, et al. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma 2011;20:196–201.
   PubMed Web of Science ®Google Scholar
• Nicosia RF, Nicosia SV, Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994;145:1023–1029.
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97–132.
   PubMed Web of Science ®Google Scholar
• Kandarakis SA, Piperi C, Moschonas DP, et al. Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats. Exp Eye Res 2015;137:1–10.
   PubMed Web of Science ®Google Scholar
• Kwak DH, Bae TH, Kim WS, Kim HK. Anti-Vascular Endothelial Growth Factor (Bevacizumab) therapy reduces hypertrophic scar formation in a rabbit ear wounding model. Arch Plast Surg 2016;43:491–497.
   PubMedGoogle Scholar
• Bao P, Kodra A, Tomic-Canic M, et al. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009;153:347–358.
   PubMed Web of Science ®Google Scholar
• Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol 2012;57:530–550.
   PubMed Web of Science ®Google Scholar
• Park HY, Kim JH, Park CK. VEGF induces TGF-β1 expression and myofibroblast transformation after glaucoma surgery. Am J Pathol 2013;182:2147–2154.
   PubMed Web of Science ®Google Scholar
• Hu DN, Gao X, Chen S, et al. Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes. J Glaucoma 2002;11:406–410.
   PubMed Web of Science ®Google Scholar
• Li Z, Hua W, Li X, Wang W. Suppression of human tenon fibroblast cell proliferation by lentivirus-mediated VEGF Small Hairpin RNA. J Ophthalmol 2017;2017:7982051.
   PubMed Web of Science ®Google Scholar
• Lopilly Park HY, Kim JH, Ahn MD, Park CK. Level of vascular endothelial growth factor in tenon tissue and results of glaucoma surgery. Arch Ophthalmol 2012;130:685–689.
   PubMedGoogle Scholar
• Chua BE, Nguyen DQ, Qin Q, et al. Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study. Clin Exp Ophthalmol 2012;40:773–779.
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Saini S. Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events. Semin Oncol 2006;33:S26–S34.
   PubMed Web of Science ®Google Scholar
• Pham B, Thomas SM, Lillie E, et al. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis. BMJ Open 2019;9:e022031.
   PubMed Web of Science ®Google Scholar
• Akkan JU, Cilsim S. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study. J Glaucoma 2015;24:1–8.
   PubMed Web of Science ®Google Scholar
• Nilforushan N, Yadgari M, Kish SK, Nassiri N. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol 2012;153:352–357.e1.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Venkatesh R, Ravindran RD. Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. J Glaucoma 2012;21:450–459.
   PubMed Web of Science ®Google Scholar
• Wells AP, Crowston JG, Marks J, et al. A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma 2004;13:454–460.
   PubMed Web of Science ®Google Scholar
• Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 1968;66:673–679.
   PubMed Web of Science ®Google Scholar
• Landers J, Martin K, Sarkies N, et al. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 2012;119:694–702.
   PubMed Web of Science ®Google Scholar
• Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983;103:84–88.
   PubMedGoogle Scholar
• Sunaric Megevand G, Bron AM. Personalising surgical treatments for glaucoma patients. Prog Retin Eye Res 2021;81:100879.
   PubMed Web of Science ®Google Scholar
• Grover DS, Kornmann HL, Fellman RL. Historical considerations and innovations in the perioperative use of Mitomycin C for glaucoma filtration surgery and bleb revisions. J Glaucoma 2020;29:226–235.
   PubMedGoogle Scholar
• Halili A, Kessel L, Subhi Y, Bach-Holm D. Needling after trabeculectomy – does augmentation by anti-metabolites provide better outcomes and is Mitomycin C better than 5-Fluoruracil? A systematic review with network meta-analyses. Acta Ophthalmol 2020;98:643–653.
   PubMed Web of Science ®Google Scholar
• WuDunn D, Cantor LB, Palanca-Capistrano AM, et al. A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. Am J Ophthalmol 2002;134:521–528.
   PubMed Web of Science ®Google Scholar
• Wong J, Wong N, Miller JW, Schuman JS. Modulation of human fibroblast activity by selected angiogenesis inhibitors. Exp Eye Res 1994;58:439–451.
   PubMed Web of Science ®Google Scholar
• Wallace HA, BM, Basehore, PM. Zito Wound healing phases. In: StatPearls. Treasure Island , FL: StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.
   Google Scholar
• Bates DO, Jones RO. The role of vascular endothelial growth factor in wound healing. Int J Low Extrem Wounds 2003;2:107–120.
   PubMedGoogle Scholar
• Ferrara N, Houck KA, Jakeman LB, et al. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991;47:211–218.
   PubMed Web of Science ®Google Scholar
• Eming SA, Krieg T. Molecular mechanisms of VEGF-A action during tissue repair. J Investig Dermatol Symp Proc 2006;11:79–86.
   PubMedGoogle Scholar
• Seong GJ, Hong S, Jung S-A, et al. TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon’s fibroblasts to myofibroblasts. Mol Vis 2009;15:2123–2128.
   PubMed Web of Science ®Google Scholar
• Hilgert CR, Hilgert AH, Odashiro AN, et al. Antiscarring effect of intraoperative bevacizumab in experimental glaucoma filtration surgery. Arq Bras Oftalmol 2018;81:316–322.
   PubMed Web of Science ®Google Scholar
• Kaushik J, Parihar JKS, Jain VK, et al. Efficacy of bevacizumab compared to Mitomycin C modulated trabeculectomy in primary open angle glaucoma: a one-year prospective randomized controlled study. Curr Eye Res 2017;42:217–224.
   PubMed Web of Science ®Google Scholar
• Kiddee W, Orapiriyakul L, Kittigoonpaisan K, et al. Efficacy of adjunctive subconjunctival bevacizumab on the outcomes of primary trabeculectomy with Mitomycin C: a prospective randomized placebo-controlled trial. J Glaucoma 2015;24:600–606.
   PubMed Web of Science ®Google Scholar
• Jampel HD, McGuigan LJ, Dunkelberger GR, et al. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol 1988;106:89–94.
   PubMedGoogle Scholar